|
|
|
Volumn 28, Issue SUPPL. 4, 1996, Pages
|
|
ACE inhibition or calcium-channel blockade: Renal implications of combinations therapy versus a single agent
a
a
|
|
Author keywords
ACE inhibitors; Calcium antagonists; Diabetes; Hypertension; Nephropathy; Pathogenesis; Proteinuria
|
|
Indexed keywords
2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
CALCIUM ANTAGONIST;
CAPTOPRIL;
CLENTIAZEM;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
EPROSARTAN;
GR 117285;
LISINOPRIL;
LOSARTAN;
NIFEDIPINE;
PLACEBO;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ANKLE EDEMA;
ANTIHYPERTENSIVE THERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
KIDNEY FUNCTION;
META ANALYSIS;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEINURIA;
RANDOMIZED CONTROLLED TRIAL;
RAT;
TREATMENT OUTCOME;
|
|
EID: 0029972331
PISSN: 01602446
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (0)
|
